Taylor and Francis Group, Molecular && Cellular Oncology, 4(5), p. e1481813
DOI: 10.1080/23723556.2018.1481813
Full text: Unavailable
Pharmacologic inhibition of KDM1A (Lysine Demethylase 1A) induces differentiation in certain subtypes of acute myeloid leukemia. Our recent studies reveal this is dependent upon drug-induced disruption of the GFI1 (Growth Factor Independent 1) transcription repressor complex, leading to activation of enhancers distributed close to genes controlling monocytic lineage differentiation.